Compare TXG & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TXG | DKL |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Natural Gas Distribution |
| Sector | Industrials | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 2019 | N/A |
| Metric | TXG | DKL |
|---|---|---|
| Price | $20.54 | $47.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 2 |
| Target Price | $15.61 | ★ $45.50 |
| AVG Volume (30 Days) | ★ 2.3M | 65.5K |
| Earning Date | 02-11-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 9.38% |
| EPS Growth | N/A | ★ 9.17 |
| EPS | N/A | ★ 3.09 |
| Revenue | $641,814,000.00 | ★ $967,420,000.00 |
| Revenue This Year | $4.50 | $11.84 |
| Revenue Next Year | N/A | $10.55 |
| P/E Ratio | ★ N/A | $15.45 |
| Revenue Growth | ★ 1.92 | N/A |
| 52 Week Low | $6.78 | $34.59 |
| 52 Week High | $21.50 | $48.97 |
| Indicator | TXG | DKL |
|---|---|---|
| Relative Strength Index (RSI) | 64.64 | 57.20 |
| Support Level | $20.01 | $45.28 |
| Resistance Level | $21.50 | $48.97 |
| Average True Range (ATR) | 1.16 | 1.51 |
| MACD | 0.30 | 0.24 |
| Stochastic Oscillator | 83.15 | 74.00 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.